Karen J Wilson insider trades

Open-market stock purchases and sales by Karen J Wilson, Director at Elicio Therapeutics, Inc, from SEC Form 4 filings since Mar 10, 2011.

Track record: 100% of 4 scored buys are up 5% or more since purchase, averaging +16%.

Recent trades

DateStockTradeValue
Aug 31, 2026ELTX Elicio Therapeutics, IncBought (not open market)—
Jun 17, 2026SER Serina Therapeutics, IncBought (not open market)—
Jun 12, 2026SER Serina Therapeutics, IncBought$8.8K
Jun 11, 2026SER Serina Therapeutics, IncBought$8.9K
May 22, 2026SER Serina Therapeutics, IncBought$19.3K
May 21, 2026SER Serina Therapeutics, IncBought$17.7K
Nov 13, 2025LVTX LAVA Therapeutics NVSold (not open market)—
Nov 13, 2025LVTX LAVA Therapeutics NVSold (not open market)—
Nov 7, 2025SER Serina Therapeutics, IncBought (not open market)—

Companies traded

  • ELTX Elicio Therapeutics, Inc: other filings, last Aug 31, 2026
  • SER Serina Therapeutics, Inc: 4 buys, last Jun 17, 2026
  • LVTX LAVA Therapeutics NV: other filings, last Nov 13, 2025
  • ANGN Angion Biomedica Corp: other filings, last Jun 9, 2022
  • VXRT Vaxart, Inc: other filings, last Jun 16, 2021
  • JAZZ Jazz Pharmaceuticals plc: 23 sales, last May 11, 2018

Get free alerts when Karen J Wilson files a new trade →